April 04, 2019
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
Tuesday, May 10, 2022
Longtime Academic and Clinical Affairs Leader, Department Chair, and Faculty Member, Tony Lehman, MD, Announces Retirement
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Anthony Lehman, MD, MSPH, who served the UMSOM for more than 30 years as Senior Associate Dean for Clinical Affairs, Department Chair, and distinguished faculty member in the UMSOM Department of Psychiatry, will retire, effective June 30, 2022.
Thursday, February 27, 2020
UMSOM Department of Psychiatry Creates New Position to Strengthen and Support Research Program
Jill RachBeisel, MD, Interim Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Gloria Reeves, MD, Associate Professor of Psychiatry, has been appointed to serve as the Vice Chair for Research of the Department.
Thursday, January 16, 2020
University of Maryland School of Medicine Research Shows That Older Patients With Untreated Sleep Apnea Need Greater Medical Care
Obstructive sleep apnea (OSA) is a common and costly medical condition leading to a wide range of health risks such as cardiovascular disease, stroke, depression, diabetes and even premature death. Researchers at the University of Maryland School of Medicine (UMSOM) found that the medical costs are substantially higher among older adults who go untreated for the disorder.
Wednesday, October 16, 2019
Researchers Discover Potential Therapy to Treat Detrimental Effects of Marijuana in Pre-Adolescent Individuals Exposed to THC in Womb
As a growing number of U.S. states legalize the medicinal and recreational use of marijuana, an increasing number of American women are using cannabis before becoming pregnant and during early pregnancy often to treat morning sickness, anxiety, and lower back pain. Although emerging evidence indicates that this may have long-term consequences for their babies’ brain development, how this occurs remains unclear.
Thursday, May 16, 2019
Dr. Christopher Welsh (SOM, UMMC) and Dr. Michelle Gourdine (UMMS) have been appointed to an opioid addiction working group by Baltimore County Executive Johnny Olszewski.
Expert working group will lead public engagement effort to gather input and develop recommendations
Wednesday, March 27, 2019
UMSOM Researchers Discover a Critical Receptor Involved in the Response to Fast-Acting Antidepressants Like Ketamine
Effective treatment of clinical depression remains a major mental health issue, with roughly 30 percent of patients who do not respond to any of the available treatments. Researchers at the University of Maryland School of Medicine (UMSOM) have discovered a crucial receptor called mGlu2 that is critical to the mechanism of fast-acting antidepressants such as ketamine when used to treat depression.
Wednesday, January 23, 2019
UMSOM'S Opioid Addiction Treatment Experts Receive Funding from CareFirst for Telemedicine Network
Addiction experts at the University of Maryland School of Medicine (UMSOM) received a $212,171 grant from CareFirst to expand access to medication assisted treatment (MAT) for opioid addiction via telemedicine to patients located on Maryland’s eastern shore.
Tuesday, October 16, 2018
Bankole A. Johnson Receives Prestigious American Society of Addiction Medicine Award
Bankole Johnson, DSc, MD, the Dr. Irving J. Taylor Professor and Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), has been named to receive the American Society of Addiction Medicine’s (ASAM) R. Brinkley Smithers Distinguished Scientist Award.
Tuesday, August 21, 2018
New Wave of Complex Street Drugs Puzzles Emergency Doctors
Study May Fuel Need for More Comprehensive Drug Testing in Hospitals
Friday, January 05, 2018
Fighting Opioid Addiction from Baltimore to Garrett County: University of Maryland School of Medicine Rises to the Challenge
The opioid epidemic has been deadly for Maryland. In 2016, more than 2000 people in the state died from overdoses; in 2017, deaths rose another 40 percent, and deaths from the powerful synthetic opioid fentanyl were up nearly 140 percent. Last year, Gov. Larry Hogan declared a state of emergency in response to the opioid epidemic, saying the state needs an “all-hands-on-deck approach.”
Wednesday, June 07, 2017
Dr. Jill RachBeisel Named Vice Chair for Clinical Affairs in UM School of Medicine’s Department of Psychiatry
Bankole A. Johnson, DSc, MD, MBChB, The Dr. Irving J. Taylor Professor and Chair for the Department of Psychiatry, Professor of Pharmacology, Anatomy and Neurobiology, along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been named Vice Chair for Clinical Affairs for the UM SOM Department of Psychiatry, commencing at the start of the next academic year.
Friday, April 29, 2016
Baltimore City Health Commissioner Speaks at University of Maryland School of Medicine Addiction Conference
Baltimore City Health Commissioner Leana Wen and other experts recently addressed ways to decrease the epidemic of opioid overdose deaths at a conference on mental health and addiction.